MAHLY Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 birž. 2024 @ 20:08):
Our systems believe the stock currently is undervalued by 3.61% compare to its pairs and should correct upwards.

Stats
Šios dienos apimtis	107
Vidutinė apimtis	33
Rinkos kapitalizacija	3.09B
EPS	$62.80 ( Q4 \| 2024-03-31 )
Kita pelno data	( $0 ) 2024-07-31
Last Dividend	$0.185 ( 2021-09-28 )
Next Dividend	$0 ( N/A )
P/E	11.75 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

CAKFY 0.00%

MAHLY 0.00%

Koreliacija (AI algo v.1.1b): Undervalued: 3.61% $15.77 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

MediPal Holdings Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

MediPal Holdings Finansinės ataskaitos

Annual	2024
Pajamos:	$3 558.73B
Bruto pelnas:	$233.01B (6.55 %)
EPS:	$195.84

FY	2024
Pajamos:	$3 558.73B
Bruto pelnas:	$233.01B (6.55 %)
EPS:	$195.84

FY	2023
Pajamos:	$3 360.01B
Bruto pelnas:	$212.12B (6.31 %)
EPS:	$184.82

FY	2022
Pajamos:	$3 290.92B
Bruto pelnas:	$205.11B (6.23 %)
EPS:	$140.13

Financial Reports:

No articles found.

MediPal Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

MediPal Holdings Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.45 - low (47.74%) | Divividend Growth Potential Score: 1.119 - No dividend expected

Information

First Dividend	$0.191	2021-03-29
Last Dividend	$0.185	2021-09-28
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.376	--
Avg. Dividend % Per Year	0.00%	--
Score	1.85	--
Div. Sustainability Score	4.45
Div.Growth Potential Score	1.119
Div. Directional Score	2.78	--

Next Divdend (Est)
(2024-12-19)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.85

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
28 Sep 2021	$0.185	30 Nov -0001	30 Nov -0001	30 Nov -0001
29 Mar 2021	$0.191	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
NACB	Ex Dividend Junior	2023-08-15	Quarterly	0.00%
ASXFY	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
IDCBY	Ex Dividend Knight	2023-07-06	Annually	0.00%
TXHPF	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
EMSHF	Ex Dividend Knight	2023-08-15	Annually	0.00%
PNBI	Ex Dividend Knight	2023-09-14	Quarterly	0.00%
CEFC	Ex Dividend Knight	2023-09-14	Quarterly	0.00%
KTHN	Ex Dividend Knight	2023-09-14	Quarterly	0.00%
AAVMY	Ex Dividend Knight	2023-08-18	Semi-Annually	0.00%
YAHOF	Ex Dividend Junior	2024-03-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0117	1.500	9.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0231	1.200	9.23	10.00	[0 - 0.3]
returnOnEquityTTM	0.0708	1.500	-0.325	-0.487	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.235	0.800	8.83	7.06	[1 - 3]
quickRatioTTM	1.047	0.800	8.55	6.84	[0.8 - 2.5]
cashRatioTTM	0.228	1.500	9.84	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6 442.12	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.0655	1.000	-2.24	-2.24	[0.2 - 0.8]
operatingProfitMarginTTM	0.0145	1.000	-1.710	-1.710	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.978	0.800	0.146	0.117	[0.5 - 2]
Total Score				4.45

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.98	1.000	8.89	0	[1 - 100]
returnOnEquityTTM	0.0708	2.50	-0.209	-0.487	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	0.0151	1.500	9.62	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0323	1.500	-3.12	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				1.119

MediPal Holdings Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.